Comprehensive survey of p94/calpain 3 substances by comparative proteomics - Possible regulation of protein synthesis by p94

Biotechnology Journal

Volumn 2, Issue 5, 2007, Pages 565-576

  Ono, Yasuko ^a   Hayashi, Chikako ^a,b   Doi, Naoko ^a,c   Kitamura, Fujiko ^a,c   Shindo, Mayumi ^d   Kudo, Kenichi ^e   Tsubata, Takuichi ^d   Yanagida, Mitsuaki ^f   Sorimachi, Hiroyuki ^a,c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d Applied Biosystems Japan Ltd   (Japan)

^e KYA TECH Corporation   (Japan)

^f JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Calpain; Fodrin; iTRAQ; Proteolysis; Substrate

Indexed keywords

CALPAIN 3; DNA 26S; ELONGATION FACTOR 1ALPHA; ELONGATION FACTOR 2; FILAMIN A; FODRIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP)(PHOSPHORYLATING); INITIATION FACTOR 3; KARYOPHERIN; KARYOPHERIN 7; LIPOCORTIN 1; LIPOCORTIN 2; SYNEXIN; THIOREDOXIN; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; VIMENTIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHEMICAL LABELING; ENZYME ACTIVITY; MASS SPECTROMETRY; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; WESTERN BLOTTING;

ANIMALS; CALPAIN; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; PROTEIN BIOSYNTHESIS; PROTEOME; PROTEOMICS; SUBSTRATE SPECIFICITY;

EUKARYOTA;

EID: 34249657818     PISSN: 18606768     EISSN: None     Source Type: Journal    
DOI: 10.1002/biot.200700018     Document Type: Article

References (47)

1. Goll, D. E., Thompson, V. F., Li, H., Wei, W. et al.. The calpain system. Physiol. Rev. 2003, 83, 731-801.
2. Suzuki, K., Hata, S., Kawabata, Y., Sorimachi, H., Structure, activation, and biology of calpain. Diabetes 2004, 53, S12-18.
3. Sorimachi, H., Ishiura, S., Suzuki, K., Structure and physiological function of calpains. Biochem. J. 1997, 328, 721-732.
4. Azam, M., Andrabi, S. S., Sahr, K. E., Kamath, L. et al., Disruption of the mouse mu-calpain gene reveals an essential role in platelet function. Mol. Cell. Biol. 2001, 21, 2213-2220.
5. Arthur, J. S., Elce, J. S., Hegadorn, C., Williams, K. et al., Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol. Cell Biol. 2000, 20, 4474-4481.
6. Dutt, P., Croall, D. E., Arthur, S. C., De Veyra, T. et al., m-Calpain is required foi preimplantation embryonic development in mice. BMC Dev. Biol. 2006, 6, DOI:10.1186/1471-213X-6-3.
7. Zimmerman, U. J., Boring, L., Pak, J. H., Mukerjee, N. et al., The calpain small subunit gene is essential: its inactivation results in embryonic lethality. IUBMB Life 2000, 50, 63-68.
8. Spencer, M. J., Mellgren, R. L., Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum. Mol. Genet. 2002, 11, 2645-2655.
9. Syntichaki, P., Xu, K., Driscoll, M., Tavernarakis, N., Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 2002, 419, 939-944.
10. Takano, J., Tomioka, M., Tsubuki, S., Higuchi, M. et al., Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J. Biol. Chem. 2005, 280, 16175-16184.
11. Kambe, A., Yokota, M., Saido, T. C., Satokata, I. et al., Spatial resolution of calpain-catalyzed proteolysis in focal cerebral ischemia. Brain Res. 2005, 1040, 36-43.
12. Higuchi, M., Tomioka, M., Takano, J., Shirotani, K. et al., Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J. Biol. Chem. 2005, 280, 15229-15237.
13. Singh, R. B., Dandekar, S. P., Elimban, V., Gupta, S. K. et al.. Role of proteases in the pathophysiology of cardiac disease. Mol. Cell. Biochem. 2004, 263, 241-256.
14. Artal-Sanz, M., Samara, C., Syntichaki, P., Tavernarakis, N., Lysosomal biogenesis and function is critical for necrotic cell death in Caenorhabditis elegans. J. Cell Biol. 2006, 173, 231-239.
15. Carragher, N. O., Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr. Pharm. Des. 2006, 12, 615-638.
16. Jiang, S. X., Lertvorachon, J., Hou, S. T., Konishi, Y. et al., Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia. J. Biol. Chem. 2005, 280, 33811-33818.
17. Ono, Y., Shimada, H., Sorimachi, H., Richard, I. et al., Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J. Biol. Chem. 1998, 273, 17073-17078.
18. Richard, I., Broux, O., Allamand, V., Fougerousse, F. et al., Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995, 81, 27-40.
19. Duguez, S., Bartoli, M., Richard, I., Calpain 3: a key regulator of the sarcomere? FEBS J. 2006, 273, 3427-3436.
20. Kramerova, I., Beckmann, J. S., Spencer, M. J., Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A). Biochim. Biophys. Acta 2007, 1772, 128-144.
21. Kramerova, I., Kudryashova, E., Wu, B., Spencer, M. J., Regulation of the M-cadherin-beta-catenin complex by calpain 3 during terminal stages of myogenic differentiation. Mol. Cell. Biol. 2006, 26, 8437-8447.
22. Kawabata, Y., Hata, S., Ono, Y., Ito, Y. et al., Newly identified exons encoding novel variants of p94/calpain 3 are expressed ubiquitously and overlap the alpha-glucosidase C gene. FEBS Lett. 2003, 555, 623-630.
23. De Tullio, R., Stifanese, R., Salamino, F., Pontremoli, S. et al., Characterization of a new p94-like calpain form in human lymphocytes. Biochem. J. 2003, 375, 689-696.
24. Konig, N., Raynaud, F., Feane, H., Durand, M. et al., Calpain 3 is expressed in astrocytes of rat and Microcebus brain. J. Chem. Neuroanat. 2003, 25, 129-136.
25. Kinbara, K., Ishiura, S., Tomioka, S., Sorimachi, H. et al.. Purification of native p94, a muscle-specific calpain, and characterization of its autolysis. Biochem. J. 1998, 335, 589-596.
26. Sorimachi, H., Toyama-Sorimachi, N., Saido, T. C., Kawasaki, H. et al., Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J. Biol. Chem. 1993, 268, 10593-10605.
27. Ono, Y., Torii, F., Ojima, K., Doi, N. et al.. Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system. J. Biol. Chem. 2006, 281, 18519-18531.
28. Ono, Y., Kakinuma, K., Torii, F., Irie, A. et al., Possible regulation of the conventional calpain system by skeletal muscle-specific calpain, p94/calpain 3. J. Biol. Chem. 2004, 279, 2761-2771.
29. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al.. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
30. Unwin, R. D., Pierce, A., Watson, R. B., Sternberg, D. W. et al., Quantitative proteomic analysis using isobaric protein tags enables rapid comparison of changes in transcript and protein levels in transformed cells. Mol. Cell. Proteomics 2005, 4, 924-935.
31. Hattan, S. J., Marchese, J., Khainovski, N., Martin, S. et al., Comparative study of [Three] LC-MALDI workflows for the analysis of complex proteomic samples. J. Proteome Res. 2005, 4, 1931-1941.
32. Dean, R A., Overall, C. M., Proteomic discovery of metalloproteinase substrates in the cellular context by iTRAQ0 labeling reveals a diverse MMP-2 substrate degradome. Mol. Cell. Proteomics 2007, 6, in press.
33. Saido, T. C., Yokota, M., Nagao, S., Yamaura, I. et al., Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 1993, 268, 25239-25243.
34. DeSouza, L., Diehl, G., Rodrigues, M. J., Guo, J. et al., Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 2005, 4, 377-386.
35. Unwin, R. D., Smith, D. L., Blinco, D., Wilson, C. L. et al., Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells. Blood 2006, 107, 4687-4694.
36. Amano, S., Kawasaki, H., Ishiura, S., Kawashima, S. et al., Identification of endogenous substrates for Drosophila calpain from a salt-extracted fraction of Drosophila ovaries. J. Biochem. 1997, 122, 865-871.
37. 2+ proteinase on murine vimentin, the mesenchymal intermediate filament protein. Biol. Chem. Hoppe Seyler 1986, 367, 1147-1152.
38. Gorlin, J. B., Yamin, R., Egan, S., Stewart, M. et al., Human endothelial actin-binding protein (ABP-280, nonmuscle nlamin): a molecular leaf spring. J. Cell Biol. 1990, 222, 1089-1105.
39. Ando, Y., Imamura, S., Hong, Y. M., Owada, M. K. et al., Enhancement of calcium sensitivity of lipocortin I in phospholipid binding induced by limited proteolysis and phosphorylation at the amino terminus as analyzed by phospholipid affinity column chromatography. J. Biol. Chem. 1989, 264, 6948-6955.
40. Taveau,M., Bourg, N., Sillon, G., Roudaut, C. et al., Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol. Cell. Biol. 2003, 23, 9127-9135.
41. Cohen, N., Kudryashova, E., Kramerova, I., Anderson, L. V. et al., Identification of putative in vivo substrates of calpain 3 by comparative proteomics of overexpressing transgenic and nontransgenic mice. Proteomics 2006, 6, 6075-6084.
42. Korzeniewski, B., Zoladz, J. A., Biochemical background of the VO2 on-kinetics in skeletal muscles. J. Physiol Sci. 2006, 56, 1-12.
43. Hayashi, M., Fukuzawa, T., Sorimachi, H., Maeda, T., Constitutive activation of the pH-responsive Rim101 pathway in yeast mutants defective in late steps of the MVB/ESCRT pathway. Mol. Cell. Biol. 2005, 25, 9478-9490.
44. Xu, W., Smith, F. J., Jr., Subaran, R., MitcheE, A. P., Multivesicular body-ESCRT components function in pH response regulation in Saccharomyces cerevisiae and Candida albicans. Mol. Biol. Cell 2004, 15, 5528-5537.
45. Kramerova, I., Kudryashova, E., Venkatiaman, G., Spencer, M. J., Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. Hum. Mol. Genet. 2005, 14, 2125-2134.
46. Schilling, O., Overall, C. M., Proteomic discovery of protease substrates. Curr. Opin. Chem. Biol. 2006, DOI:10.1016/ j.cbpa.2006.11.037.
47. Hopgood, M. F., Knowles, S. E., Ballard, F. J., Proteolysis of N-ethyl-maleimide-modified aldolase loaded into erythrocyte ghosts: prevention by inhibitors of calpain. Biochem. J. 1989, 259, 237-242.